SEARCH

SEARCH BY CITATION

References

  • Adachi-Uehara N., Kato M., Nimura Y. et al. (2006) Up-regulation of genes for oxidative phosphorylation and protein turnover in diabetic mouse retina. Exp. Eye Res. 83, 849857.
  • Aniksztejn L. and Ben-Ari Y. (1991) Novel form of long-term potentiation produced by a K+ channel blocker in the hippocampus. Nature 349, 6769.
  • Anouar Y., Desmoucelles C., Yon L., Leprince J., Breault L., Gallo-Payet N. and Vaudry H. (1998) Identification of a novel secretogranin II-derived peptide (SgII187-252) in adult and fetal human adrenal glands using antibodies raised against the human recombinant peptide. J. Clin. Endocrinol. Metab. 83, 29442951.
  • Bateup H. S., Santini E., Shen W., Birnbaum S., Valjent E., Surmeier D. J., Fisone G., Nestler E. J. and Greengard P. (2010) Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proc. Natl Acad. Sci. USA 107, 1484514850.
  • Beutler L. R., Wanat M. J., Quintana A., Sanz E., Bamford N. S., Zweifel L. S. and Palmiter R. D. (2011) Balanced NMDA receptor activity in dopamine D1 receptor (D1R)- and D2R-expressing medium spiny neurons is required for amphetamine sensitization. Proc. Natl Acad. Sci. USA 108, 42064211.
  • Blazquez M., Bosma P. T., Chang J. P., Docherty K. and Trudeau V. L. (1998) Gamma-aminobutyric acid up-regulates the expression of a novel secretogranin-II messenger ribonucleic acid in the goldfish pituitary. Endocrinology 139, 48704880.
  • Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156159.
  • Cibelli G., Jungling S., Schoch S., Gerdes H. H. and Thiel G. (1996) Identification of a functional cAMP response element in the secretogranin II gene. Eur. J. Biochem. 236, 171179.
  • Dai R., Ali M. K., Lezcano N. and Bergson C. (2008) A crucial role for cAMP and protein kinase A in D1 dopamine receptor regulated intracellular calcium transients. Neurosignals 16, 112123.
  • David H. N., Ansseau M. and Abraini J. H. (2005) Dopamine-glutamate reciprocal modulation of release and motor responses in the rat caudate-putamen and nucleus accumbens of “intact” animals. Brain Res. Rev. 50, 336360.
  • Day J. J. and Sweatt J. D. (2011) Epigenetic mechanisms in cognition. Neuron 70, 813829.
  • Fiorentini C., Gardoni F., Spano P., Di Luca M. and Missale C. (2003) Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors. J. Biol. Chem. 278, 2019620202.
  • Fischer-Colbrie R., Laslop A. and Kirchmair R. (1995) Secretogranin II: molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin. Prog. Neurobiol. 46, 4970.
  • Flavell S. W. and Greenberg M. E. (2008) Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system. Annu. Rev. Neurosci. 31, 563590.
  • Fujita Y., Katagi J., Tabuchi A., Tsuchiya T. and Tsuda M. (1999) Coactivation of secretogranin-II and BDNF genes mediated by calcium signals in mouse cerebellar granule cells. Brain Res. Mol. Brain Res. 63, 316324.
  • Fukunaga K., Soderling T. R. and Miyamoto E. (1992) Activation of Ca2+/calmodulin-dependent protein kinase II and protein kinase C by glutamate in cultured rat hippocampal neurons. J. Biol. Chem. 267, 2252722533.
  • Gasser M. C., Berti I., Hauser K. F., Fischer-Colbrie R. and Saria A. (2003) Secretoneurin promotes pertussis toxin-sensitive neurite outgrowth in cerebellar granule cells. J. Neurochem. 85, 662669.
  • Greer P. L. and Greenberg M. E. (2008) From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function. Neuron 59, 846860.
  • Hasbi A., Fan T., Alijaniaram M., Nguyen T., Perreault M. L., O'Dowd B. F. and George S. R. (2009) Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth. Proc. Natl Acad. Sci. USA 106, 2137721382.
  • Hikida T., Kimura K., Wada N., Funabiki K. and Nakanishi S. (2010) Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior. Neuron 66, 896907.
  • Huang Y. Y. and Malenka R. C. (1993) Examination of TEA-induced synaptic enhancement in area CA1 of the hippocampus: the role of voltage-dependent Ca2+ channels in the induction of LTP. J. Neurosci. 13, 568576.
  • Hyman S. E., Malenka R. C. and Nestler E. J. (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 29, 565598.
  • Iwase K., Iyama K., Akagi K., Yano S., Fukunaga K., Miyamoto E., Mori M. and Takiguchi M. (1998) Precise distribution of neuronal nitric oxide synthase mRNA in the rat brain revealed by non-radioisotopic in situ hybridization. Brain Res. Mol. Brain Res. 53, 112.
  • Iwase K., Miyanaka K., Shimizu A., Nagasaki A., Gotoh T., Mori M. and Takiguchi M. (2000) Induction of endothelial nitric-oxide synthase in rat brain astrocytes by systemic lipopolysaccharide treatment. J. Biol. Chem. 275, 1192911933.
  • Jonas P., Racca C., Sakmann B., Seeburg P. H. and Monyer H. (1994) Differences in Ca2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression. Neuron 12, 12811289.
  • Jones L. C. and Scammell J. G. (1998) The cAMP-response element mediates induction of secretogranin II by CHX and FSK in GH4C1 cells. Am. J. Physiol. 274, E656E664.
  • Kandel E. R. (2001) The molecular biology of memory storage: a dialogue between genes and synapses. Science 294, 10301038.
  • Kelley A. E. (2004) Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron 44, 161179.
  • Kirchmair R., Hogue-Angeletti R., Gutierrez J., Fischer-Colbrie R. and Winkler H. (1993) Secretoneurin—a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C). Neuroscience 53, 359365.
  • Kirchmair R., Gander R., Egger M. et al. (2004) The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivo. Circulation 109, 777783.
  • Kisilevsky A. E., Mulligan S. J., Altier C. et al. (2008) D1 receptors physically interact with N-type calcium channels to regulate channel distribution and dendritic calcium entry. Neuron 58, 557570.
  • Konopka D., Nowicka D., Filipkowski R. K. and Kaczmarek L. (1995) Kainate-evoked secondary gene expression in the rat hippocampus. Neurosci. Lett. 185, 167170.
  • Kravitz A. V., Freeze B. S., Parker P. R. L., Kay K., Thwin M. T., Deisseroth K. and Kreitzer A. C. (2010) Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 466, 622626.
  • LeDoux J. E. (2000) Emotion circuits in the brain. Annu. Rev. Neurosci. 23, 155184.
  • Lee F. J. S., Xue S., Pei L., Vukusic B., Chéry N., Wang Y., Wang Y. T., Niznik H. B., Yu X. M. and Liu F. (2002) Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell 111, 219230.
  • Li L., Hung A. C. and Porter A. G. (2008) Secretogranin II: a key AP-1-regulated protein that mediates neuronal differentiation and protection from nitric oxide-induced apoptosis of neuroblastoma cells. Cell Death Differ. 15, 879888.
  • Lisman J., Grace A. A. and Duzel E. (2011) A neoHebbian framework for episodic memory; role of dopamine-dependent late LTP. Trends Neurosci. 34, 536547.
  • Liu X. Y., Chu X. P., Mao L. M. et al. (2006) Modulation of D2R-NR2B interactions in response to cocaine. Neuron 52, 897909.
  • Mioduszewska B., Jaworski J. and Kaczmarek L. (2003) Inducible cAMP early repressor (ICER) in the nervous system—a transcriptional regulator of neuronal plasticity and programmed cell death. J. Neurochem. 87, 13131320.
  • Murray A. J. (2008) Pharmacological PKA inhibition: all may not be what it seems. Sci. Signal. 1, re4.
  • Navakkode S., Sajikumar S. and Frey J. U. (2007) Synergistic requirements for the induction of dopaminergic D1/D5-receptor-mediated LTP in hippocampal slices of rat CA1 in vitro. Neuropharmacology 52, 15471554.
  • Nedivi E., Hevroni D., Naot D., Israeli D. and Citri Y. (1993) Numerous candidate plasticity-related genes revealed by differential cDNA cloning. Nature 363, 718722.
  • Nicol L., McNeilly J. R., Stridsberg M., Crawford J. L. and McNeilly A. S. (2002) Influence of steroids and GnRH on biosynthesis and secretion of secretogranin II and chromogranin A in relation to LH release in LßT2 gonadotroph cells. J. Endocrinol. 174, 473483.
  • Ohtsuka S., Iwase K., Kato M. et al. (2004) An mRNA amplification procedure with directional cDNA cloning and strand-specific cRNA synthesis for comprehensive gene expression analysis. Genomics 84, 715729.
  • Pape H. C. and Pare D. (2010) Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiol. Rev. 90, 419463.
  • Pascoli V., Turiault M. and Lüscher C. (2012) Reversal of cocaine-evoked synaptic potentiation resets drug-induced adaptive behaviour. Nature 481, 7176.
  • Saria A., Troger J., Kirchmair R., Fischer-Colbrie R., Hogue-Angeletti R. and Winkler H. (1993) Secretoneurin releases dopamine from rat striatal slices: a biological effect of a peptide derived from secretogranin II (chromogranin C). Neuroscience 54, 14.
  • Sassone-Corsi P. (1998) Coupling gene expression to cAMP signalling: role of CREB and CREM. Int. J. Biochem. Cell Biol. 30, 2738.
  • Scammell J. G. and Valentine D. L. (1994) Induction of secretogranin II mRNA by protein synthesis inhibitors in GH4C1 cells. Am. J. Physiol. 267, E656E661.
  • Scammell J. G., Sumners C., Reutter M. A., Valentine D. L. and Jones L. C. (1995) Regulation of secretogranin II mRNA in rat neuronal cultures. Brain Res. Mol. Brain Res. 33, 326332.
  • Scammell J. G., Reddy S., Valentine D. L., Coker T. N., Nikolopoulos S. N. and Ross R. A. (2000) Isolation and characterization of the human secretogranin II gene promoter. Brain Res. Mol. Brain Res. 75, 815.
  • Shen W., Flajolet M., Greengard P. and Surmeier D. J. (2008) Dichotomous dopaminergic control of striatal synaptic plasticity. Science 321, 848851.
  • Shyu W. C., Lin S. Z., Chiang M. F., Chen D. C., Su C. Y., Wang H. J., Liu R. S., Tsai C. H. and Li H. (2008) Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke. J. Clin. Invest. 118, 133148.
  • So C. H., Verma V., Alijaniaram M., Cheng R., Rashid A. J., O'Dowd B. F. and George S. R. (2009) Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers. Mol. Pharmacol. 75, 843854.
  • Song S. B., Rhee M., Roberson M. S., Maurer R. A. and Kim K. E. (2003) Gonadotropin-releasing hormone-induced stimulation of the rat secretogranin II promoter involves activation of CREB. Mol. Cell. Endocrinol. 199, 2936.
  • Tang T. S. and Bezprozvaany I. (2004) Dopamine receptor-mediated Ca2+ signaling in striatal medium spiny neurons. J. Biol. Chem. 279, 4208242094.
  • Taupenot L., Harper K. L. and O'Connor D. T. (2003) The chromogranin-secretogranin family. N. Engl. J. Med. 348, 11341149.
  • Valjent E., Pascoli V., Svenningsson P. et al. (2005) Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl Acad. Sci. USA 102, 491496.
  • Wiedermann C. J. (2000) Secretoneurin: a functional neuropeptide in health and disease. Peptides 21, 12891298.
  • Xie J. and Roberson M. S. (2008) 3’,5’-Cyclic adenosine 5’-monophosphate response element-dependent transcriptional regulation of the secretogranin II gene promoter depends on gonadotropin-releasing hormone-induced mitogen-activated protein kinase activation and the transactivator activating transcription factor 3. Endocrinology 149, 783792.
  • Yajima A., Ikeda M., Miyazaki K., Maeshima T., Narita N. and Narita M. (2004) Manserin, a novel peptide from secretogranin II in the neuroendocrine system. NeuroReport 15, 17551759.
  • Yoshikawa T., Nagasugi Y., Azuma T., Kato M., Sugano S., Hashimoto K., Masuho Y., Muramatsu M. and Seki N. (2000) Isolation of novel mouse genes differentially expressed in brain using cDNA microarray. Biochem. Biophys. Res. Commun. 275, 532537.
  • You Z. B., Saria A., Fischer-Colbrie R., Terenius L., Goiny M. and Herrera-Marschitz M. (1996) Effects of secretogranin II-derived peptides on the release of neurotransmitters monitored in the basal ganglia of the rat with in vivo microdialysis. Naunyn Schmiedebergs Arch. Pharmacol. 354, 717724.